Yuan Zheng, Ghosh Debashis
Eli Lilly and Company, Indianapolis, Indiana 46285, USA.
Biometrics. 2008 Jun;64(2):431-9. doi: 10.1111/j.1541-0420.2007.00904.x. Epub 2008 Mar 5.
In medical research, there is great interest in developing methods for combining biomarkers. We argue that selection of markers should also be considered in the process. Traditional model/variable selection procedures ignore the underlying uncertainty after model selection. In this work, we propose a novel model-combining algorithm for classification in biomarker studies. It works by considering weighted combinations of various logistic regression models; five different weighting schemes are considered in the article. The weights and algorithm are justified using decision theory and risk-bound results. Simulation studies are performed to assess the finite-sample properties of the proposed model-combining method. It is illustrated with an application to data from an immunohistochemical study in prostate cancer.
在医学研究中,人们对开发生物标志物组合方法有着浓厚的兴趣。我们认为在这个过程中也应该考虑标志物的选择。传统的模型/变量选择程序忽略了模型选择后潜在的不确定性。在这项工作中,我们提出了一种用于生物标志物研究分类的新型模型组合算法。它通过考虑各种逻辑回归模型的加权组合来工作;本文考虑了五种不同的加权方案。使用决策理论和风险边界结果对权重和算法进行了论证。进行了模拟研究以评估所提出的模型组合方法的有限样本性质。通过应用于前列腺癌免疫组织化学研究的数据进行了说明。